Scientific Sessions 2025  /  Personalized, Potent, and Precise: The Evolving Drug Landscape in AMI  /  Frontline Pharmaco-Tactics: Optimizing Pre-Hospital and Early In-Hospital Medication in STEMI
Logo

American Heart Association

  61
  0

Final ID:

Frontline Pharmaco-Tactics: Optimizing Pre-Hospital and Early In-Hospital Medication in STEMI

  • Cohen, Mauricio  ( Cleveland Clinic Florida , Weston , Florida , United States )
  • Tarantini, Giuseppe  ( University of Padova , Padova , Italy )
    • Author Disclosures:
    Mauricio Cohen: DO have relevant financial relationships ; Consultant:Abbott:Active (exists now) ; Ownership Interest:Accumed Radial:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) ; Consultant:Edwards:Active (exists now) ; Consultant:Cordis:Active (exists now) | Giuseppe Tarantini: DO have relevant financial relationships ; Speaker:Edwrard's Lifescience:Active (exists now) ; Speaker:GADA:Active (exists now) ; Speaker:SMT:Active (exists now) ; Speaker:Boston Scientific:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Personalized, Potent, and Precise: The Evolving Drug Landscape in AMI

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Next-Gen Antiplatelet and Anticoagulant Therapies in AMI: Moving Beyond the Standard of Care

Rymer Jennifer

Emerging Therapies in AMI: Targeting Inflammation and Microvascular Obstruction

Ridker Paul

More abstracts from these authors:
Culprit-Only or Complete? Revascularization Dilemmas in Cardiogenic Shock

Thiele Holger, Cohen Mauricio

Fibrinolytics vs PCI for STEMI: The case for improved flow, not just patency of the vessel.

Cohen Mauricio

You have to be authorized to contact abstract author. Please, Login
Not Available